These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38423689)

  • 1. Superficial and Bullous Neutrophilic Dermatoses: Sneddon-Wilkinson, IgA Pemphigus, and Bullous Lupus.
    Manjaly P; Sanchez K; Gregoire S; Ly S; Kamal K; Mostaghimi A
    Dermatol Clin; 2024 Apr; 42(2):307-315. PubMed ID: 38423689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bullous, pseudobullous, & pustular dermatoses.
    Wick MR
    Semin Diagn Pathol; 2017 May; 34(3):250-260. PubMed ID: 28108048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bullous systemic lupus erythematosus: An uncommon manifestation in pediatric population.
    Hasbún Z MT; Rollan MP; Chaparro R X; Fischer S C; Castrillón V A; González B S; Reculé F
    Andes Pediatr; 2021 Jun; 92(3):428-433. PubMed ID: 34479250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bullous systemic lupus erythematosus with lupus nephritis: a rare case of a subepidermal bullous disorder in a child.
    Poojary S; Rais S
    Cutis; 2012 Jan; 89(1):17-21. PubMed ID: 22439305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bullous systemic lupus erythematosus: a review and update to diagnosis and treatment.
    Contestable JJ; Edhegard KD; Meyerle JH
    Am J Clin Dermatol; 2014 Dec; 15(6):517-24. PubMed ID: 25358414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel immune-mediated subepidermal bullous dermatosis characterized by IgG autoantibodies to a lower lamina lucida component.
    Chan LS; Cooper KD
    Arch Dermatol; 1994 Mar; 130(3):343-7. PubMed ID: 8129413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bullous systemic lupus erythematosus.
    Yung A; Oakley A
    Australas J Dermatol; 2000 Nov; 41(4):234-7. PubMed ID: 11105368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic bullous dermatosis of childhood.
    Tomecki KJ
    South Med J; 1983 May; 76(5):651-3. PubMed ID: 6342155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linear IgA bullous dermatosis. Characterization of a subset of patients with concurrent IgA and IgG anti-basement membrane autoantibodies.
    Chan LS; Traczyk T; Taylor TB; Eramo LR; Woodley DT; Zone JJ
    Arch Dermatol; 1995 Dec; 131(12):1432-7. PubMed ID: 7492134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune bullous dermatoses: a review.
    Patrício P; Ferreira C; Gomes MM; Filipe P
    Ann N Y Acad Sci; 2009 Sep; 1173():203-10. PubMed ID: 19758152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of bullous lupus with corticosteroids and belimumab: A case report.
    Keshavamurthy C; Fibeger E; Virata A; Bansal P
    Mod Rheumatol Case Rep; 2023 Jan; 7(1):52-56. PubMed ID: 35538618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bullous systemic lupus erythematosus successfully treated with rituximab.
    Lowe CD; Brahe CA; Green B; Lam TK; Meyerle JH
    Cutis; 2019 Jun; 103(6):E5-E7. PubMed ID: 31348461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 vaccine-triggered conversion from systemic lupus erythematosus (SLE) to bullous SLE and dipeptidyl peptidase 4 inhibitors-associated bullous pemphigoid.
    Nakahara Y; Yamane M; Sunada M; Aoyama Y
    J Dermatol; 2023 Feb; 50(2):162-165. PubMed ID: 36578130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of Direct Immunofluorescence Studies in Subclassification of Autoimmune Sub-Epidermal Bullous Diseases: A 2-Year Study in a Tertiary Care Hospital.
    Jain S; Basavaraj V; Vimala MG
    Turk Patoloji Derg; 2016; 32(2):91-8. PubMed ID: 27136107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune bullous skin diseases. Part 1: Clinical manifestations.
    Kneisel A; Hertl M
    J Dtsch Dermatol Ges; 2011 Oct; 9(10):844-56; quiz 857. PubMed ID: 21955378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic importance of immunofluorescence in oral bullous diseases and lupus erythematosus.
    Nisengard RJ; Jablonska S; Beutner EH; Shu S; Chorzelski TP; Jarzabek M; Blaszczyk M; Rzesa G
    Oral Surg Oral Med Oral Pathol; 1975 Sep; 40(3):365-75. PubMed ID: 1101128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, histological, immunological presentations and outcomes of bullous systemic lupus erythematosus: 10 New cases and a literature review of 118 cases.
    de Risi-Pugliese T; Cohen Aubart F; Haroche J; Moguelet P; Grootenboer-Mignot S; Mathian A; Ingen-Housz-Oro S; Hie M; Wendremaire N; Aucouturier F; Lepelletier F; Miyara M; Bader-Meunier B; Rémy P; Fabien N; Francès C; Barete S; Amoura Z
    Semin Arthritis Rheum; 2018 Aug; 48(1):83-89. PubMed ID: 29191376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lupus erythematosus-specific bullous lesions.
    Smith KN; Maddy AJ; Motaparthi K
    Dermatol Online J; 2023 Dec; 29(6):. PubMed ID: 38478668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bullous Systemic Lupus Erythematosus: Case report.
    Miziara ID; Mahmoud A; Chagury AA; Alves RD
    Int Arch Otorhinolaryngol; 2013 Jul; 17(3):344-6. PubMed ID: 25992032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case of shift from linear immunoglobulin A bullous dermatosis to pemphigus herpetiformis for a short period of time.
    Koga H; Ishii N; Hashimoto T; Nakama T
    J Dermatol; 2017 Feb; 44(2):189-193. PubMed ID: 28497856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.